Industry
Hecto Healthcare reveals HH202-LB development results, body fat down 1.92 kg
Hecto Healthcare disclosed development results for its probiotic ingredient HH202-LB, which it says helps gut health, at the 2026 International Academic Conference of the Korean Society of Food Science and Nutrition in Jeju. The company said HH202-LB received individual recognition this year from the Ministry of Food and Drug Safety for functionality that may help reduce body fat. It also said a 12-week human trial in overweight adults showed about a 1.92 kg decrease in body fat in the test group.
